We found that these NK/T-cell immune responses coincided with relative depletion of NKG2A-positive NK-cells and CD8+ T-cells, suggesting an early role of NKG2A loss/downregulation in permitting anti-tumour responses. This evidence concerns the gene KLRC1 and neoplasm.